P

Portage Biotech
D

PRTG

4.57000
USD
-0.13
(-2.77%)
مغلق
حجم التداول
200
الربح لكل سهم
-13
العائد الربحي
-
P/E
-0
حجم السوق
7,519,702
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Portage Biotech Inc

القطاع: Healthcare
الصناعة: Biotechnology
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immuneresistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.